Embark Laboratories
PrivateLast Round
M&A
Aug 30, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Embark Laboratories operates in Healthcare & Life Sciences and is based in Copenhagen. It was founded in 2023.
Embark Laboratories is a biotechnology company that focuses on the discovery and development of novel therapeutic targets for cardiometabolic diseases, including obesity and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embark Laboratories Comparables
Compare Embark Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incipiam Pharma | 79% | |
| Antag Therapeutics | 69% | |
| Equator Therapeutics | 69% |
For institutional investors. Book with your work email.
Embark Laboratories Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Embark Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Seed |
| Novo Nordisk Foundation | Seed |
| Novo Holdings | Seed |
| European Research Council | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 661% MoM, from 66 to 502.
- Apr 22, 2026
Monthly visitors grew 155% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Embark Laboratories Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Embark Laboratories's valuation, stock price, and market status.
Is Embark Laboratories a public or private company?
Embark Laboratories is a private company.
What is the current stock price of Embark Laboratories?
Embark Laboratories is a private company, so its shares have no public market price. Caplight tracks Embark Laboratories's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Embark Laboratories worth (valuation)?
Valuation information for Embark Laboratories is not publicly available.
Can I buy Embark Laboratories stock?
Embark Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Embark Laboratories's last funding round?
Embark Laboratories's most recent funding round was M&A on August 30, 2023.
Who are the main investors in Embark Laboratories?
Key investors in Embark Laboratories include Innovation Fund Denmark, Novo Nordisk Foundation, Novo Holdings, European Research Council.
Will Embark Laboratories IPO soon?
No public IPO plans have been announced for Embark Laboratories.
How can I track Embark Laboratories secondary market activity?
Caplight tracks bids, offers, and trades in Embark Laboratories's shares on secondary markets.